Philip Tsai, Chief Technical Officer at Immunome Inc. (IMNM), bought 20,000 shares at $20.49 ($410K) on 2025-12-19, disclosed to the SEC on 2025-12-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.49 | 10,000 | $205K | 50.0% |
| 2 | $20.49 | 10,000 | $205K | 50.0% |
| Total | $20.49 avg | 20,000 | $410K | 100% |
| Filing → |